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1. Introduction
  Salmonella enterica serovar Typhi (S. typhi) are Gram-
negative, motile, non-lactose fermenting, facultative, 
intracellular pathogenic bacteria causing typhoid fever 
exclusively in humans, responsible for both morbidity and 
mortality in worldwide. It has been well documented that 
typhoid fever is a systemic infection characterized by the 
presence of S. typhi in the liver, spleen, and bone marrow, 
invades and survives within macrophages and tissues of the 
reticuloendothelial system[1]. S. typhi colonizes gall bladder 
and survive in the infected individual after the symptoms 
disappeared, serving as a reservoir for the spreading of 
the typhoid fever[2]. In developing countries, Salmonellae 
infection poses a greatest health concern in the water, food 
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industry[3] and continues to be a worldwide health problem. 
It has been reported that the morbidity of typhoid fever is 
highest in Asia with 93% of the global level (WHO). Number 
of studies has been describing the emergence of multidrug 
resistant S. typhi which renders concern on use of antibiotics 
in the treatment process[4-8]. Given the fact, currently use of 
vaccines to prevent the Salmonellae infections holds great 
promise in clinical research as an alternative approach 
to antibiotics as well to reduce the disease burden. It has 
been reported that S. typhi like other enteric pathogens 
has to respond quickly to the changing host environments 
encountered in vivo, which will exert different demands 
and stresses ie. osmolarity, pH, oxygen tension and nutrient 
starvation on the bacterial cell[1].  Bacteria possess systems 
for sensing these external environments, responding by 
co-ordinately controlling the expression of genes whose 
products are employed to assist survival under different 
condition[9]. 
  Traditional approaches to the development of vaccines for 
bacterial diseases include parenteral injection of purified 
components of live vaccines or killed whole cell organisms. 
In contrast live oral vaccines have several advantages over 
parenteral vaccine such as low cost, easy to preparation 
and administration, safe to the organism as well as to the 
administrator. But the development of live vaccines has 
limitations such as understanding of the pathogenesis of 
the disease at molecular level. It is prerequisite that the 
candidate live vaccine strains must be non- revertable 
genetic alterations that affect the virulence of the organism, 
but not its induction of an immune response. Attenuation 
of virulent Salmonella strains has been demonstrated by 
evaluating Salmonella typhimurium mutants in the murine 
typhoid model[10]. 
  Several classes and combinations of mutant of Salmonella 
typhimurium attenuation have already been reported, 
including those with mutations in genes encoding key 
enzymes in the aromatic biosynthetic pathway (aro mutants)
[11] and those with mutations in controlling the expression of 
genes in response to environmental stimuli (ompR mutants)
[12]. It has been well documented that attenuated strains of 
S. typhi in humans can stimulate both humoral and cell-
mediated immune responses. It is proven that cell-mediated 
immune responses are very important mediators of the 
protection conferred by Ty21a and other attenuated S. typhi 
live oral vaccine strains[13].
  CVD 909 live attenuated S. typhi induces cell mediated 
immune response, however second dose affects ability due 
to constitutive expression of Vi Ag[14]. S. typhi Ty2 derivative 
TSB7 harbouring deletion mutation in ssaVand aroC 
demonstrated to elicite immune response[15].
  The importance of ompR-envZ genes is well characterized 
in S. typhi in response to osmolar stress and its virulence 
in human beings[10]. Moreover, the mutation in ompR can 
attenuate the virulence characteristics also reported[1]. 
Considering the importance of NaCl concentration in the 
expression of ompR gene in the present study, we propose 
that a high osmolar concentration can be a strong stress 
and used for induction of deletion mutations in ompR gene 
to attain attenuated strains which is not revert in animal 
models to develop candidate vaccines.
2. Materials and methods
2.1. Sample collection
  Early morning stool samples were collected from the 
asymptomatic typhoid carriers in Namakkal District and 
transported to the laboratory using screw-capped tubes with 
Cary-Blair medium. 
2.2. Identification of S. typhi strains
  The preliminary morphological and biochemical tests[16] 
were performed for the identification of S. typhi including 
Gram’s staining, motility test, catalase test, oxidase test, 
sugar fermentation, indole test, methyl red test, voges- 
proskauer test, citrate utilization test, triple sugar iron test 
and urease test. S. typhi was also identified based on the 
growth pattern on enrichment medium (Selenite-F broth), 
Differential medium (Mac Conkey Agar), and Selective 
medium (Bismuth Sulphite Agar, Xylose, Lysine and 
Deoxycholate Agar).
2.3. Confirmatory test for identification of S. typhi strains
  The bacterial agglutination test (high titre serum 
agglutination test) was adopted to identify S. typhi[17]. A 
drop of saline was placed in clean microscopic slide and a 
small amount of culture of S. typhi from the solid medium 
was emulsified using inoculation loop followed by a drop 
of antiserum (SPAN) of S. typhi was added and mixed with 
sterile stick. The slide was observed for agglutination within 
2 min. 
2.4. Induction of mutation on SS3 and SS5 strains
  LB broth was prepared and various concentrations 
of sodium chloride ranging from 0.1 to 0.7 M were 
supplemented. S. typhi SS3 and SS5 strains were inoculated 
into the LB broth and incubated for two weeks of period 
with repeated subculture. From these cultures, DNA was 
isolated[18] and subjected to amplification of ompR gene 
using MGR 06 and MGR 07 primers[1].
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2.5. Polymerase chain reaction (PCR)
  Total genomic DNA of S. typhi isolates grown on LB 
broth was prepared by phenol/chloroform/isoamyl alcohol 
extraction (25:24:1) and spooling from ethanol, as described 
by Sambrooke et al[19]. RNA contamination in DNA was 
eliminated using RNase A (BioBasic INC, Canada) PCR was 
performed in a final volume of 50 毺L containing 1 毺L of 
genomic DNA (100 毺g) as template, 0.5 毺L of each primer, 
(ompR gene forward primer 5’AGG GGC GTT TTC ATC 
TCG-3’ (MGR 06) and reverse primer 5’-ACC AGG CTG ACG 
AAC AG-3’ (MGR 07) (First Base, Singapore) (20 毺m), 48 
毺L of Master Mix (Promega) to make a final concentration 
of 15 mM MgCl2, 100 mM Tris-Hydrochloride, 4 毺L of 2.5 
mM dNTPs mix (dATP, dCTP, dGTP, dTTP) and 2.5 Units 
of Thermo stable DNA polymerase (Promega). Subsequent 
amplifications were then performed in a Thermal Cycler 
(Techgene, UK), according to the following profile: 35 cycles 
of 2 min at 94 曟, 30 sec at 94 曟, 1 min at 49 曟, 1 min at 72 
曟 for extension, and 7 min at 72 曟 for the final extension. 
Amplified products were purified using Eppendrof 
perfectprep gel cleanup kit and analyzed by electrophoresis 
in 1% (w/v) agarose (Sigma) gel. DNA sequence was done 
by automated sequencer at MWG Biotech Private Limited, 
Bangalore, India. DNA sequence data reported here was 
deposited in GenBank under the accession number of 
EU834745 and EU849617.
2.6. Detection of Vi antigen in SS3 and SS5 strains 
  S. typhi strains were placed on a clean glass slide, heated 
at 60 曟 for 30 min and cool. Equal amount of Vi antiserum 
(Acme Progen Biotech India Pvt Ltd, India) was placed and 
mixed gently for agglutination test[1].
2.7. Detection of intra cellular accumulation of Vi 
polysaccharide 
  S. typhi strains were grown overnight on LB agar (Hi 
Media) plates containing aromatic compounds at 37 曟.
Cells were harvested, suspended in PBS and the optical 
density was adjusted to 0.8-1.0 at 650 nm. Then the cells 
were disrupted by sonication in 30 sec bursts for a total of 
2.5 min with an interval of 30 sec on ice. Counter current 
immunoelctrophoresis was done[20] to detect intracellular 
accumulation of Vi polysaccharide.
2.8. Outer membrane protein isolation from SS3 and SS5 
wild and mutant strains
  To begin with total cell, envelopes were removed by 
sonication of aerobically grown LB broth cultures. The 
sonication was carried out with 5 mL aliquots of cells 
(OD at 650 nm of 0.8-1.0) suspended in 10 mM sodium 
phosphate buffer (pH 7.2). The resulting sonicated material 
was subjected to centrifugation to remove the cell debris 
at 100 000 g for 10 min. Eventually, the inner membrane 
was solubilized by 1% sodium lauryl sarcosinate treatment, 
and outer membrane enriched fraction was collected by a 
final centrifugation at 100 000 g for 30 min. The pellets were 
resuspended in phosphate buffer and then analyzed in 10% 
SDS-PAGE[21]. 
2.9. Assessment of virulence in mice 
  Six mice per group for SS3 and SS5 wild type strains and 
mutants were used. Female mice aged 6-8 weeks were used 
to determine LD50 of the wild strains with 0.5 mL doses of log 
phase culture of attenuated SS3 and SS5 strains of having 
3 log CFU.mL-1. Second injection was being given on 8th 
day with the same dose. After the 14th day mice was bleed 
by retero orbital plexus. The antiserum was separated and 
stored in aliquots with 0.1% sodium azide (Merck) at -20 曟[22].
Mice were injected intraperitoneally with various log phase 
culture (12 h of LB broth culture again inoculated in the LB 
broth and incubated for 3 h) of 10 fold dilutions of SS3 and 
SS5 wild isolates were used. The animals were monitored for 
morbidity and mortality[23,24].
3. Results
3.1. Identification of S. typhi strains 
  Based on biochemical tests and specific morphological 
growth characteristics in the respective medium such as the 
production of red colour deposits in the Selenite F broth, 
jet-black colour colonies on BSA, red smooth colonies 
on XLD and colourless colonies on Mac Conkey agar, the 
isolates were identified as S. typhi. A clear agglutination of 
emulsified colony confirms the isolates were S. typhi, with 
antiserum on the glass slide (bacterial agglutination test). 
3.2. Amplification of ompR gene encoding the virulence 
region SS3 and SS5 strains
  PCR primers MGR 06 (F) and MGR 07(R) corresponding 
to the region of ompR used to amplify the chromosomal 
DNA from S. typhi isolates. The PCR products of ompR 
genes were analyzed by agarose gel electrophoresis. The 
amplified product was also compared with standard DNA 
ladder (Sigma). S. typhi SS3 and SS5 strains were give rise to 
799 bp for ompR (Figure 1). In case of the mutants, 282 bp 
ompR gene products (Figure 2) were observed using same 
MGR 06 (F) and MGR 07 (R) primers, and 517 bp was found 
to be deleted due to osmolar stress at 0.5, 0.6 and 0.7 M NaCl 
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(Table 1).
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Figure 1. Amplified ompR gene of S. typhi wild strains.
Lane1-1 kb DNA ladder (Sigma), Lane 2- S. typhi SS3, Lane 3- S. typhi 
SS5.
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Figure 2. Amplified ompR gene of S. typhi mutant strains.
Lane1: 1 kb DNA ladder (Sigma), Lane 2: S. typhi SS3, Lane 3: S. typhi 
SS5.
Table 1
NaCl concentration to induce mutation on S. typhi SS 3 and SS 5 
strains.
S. typhi strains Osmolar 
concentration (M)
OmpR PCR 
product (bp)
Remarks
SS3 SS5 0.1 799 Wild
SS3 SS5 0.2 799 Wild
SS3 SS5 0.3 799 Wild
SS3 SS5 0.4 799 Wild
SS3 SS5 0.5 282 Mutant
SS3 SS5 0.6 282 Mutant
SS3 SS5 0.7 282 Mutant
3.3. Intra cellular accumulation of Vi polysaccharide 
  The lack of agglutination of ompR mutants with antiserum 
was due to a defect in the expression of Vi polysaccharide. 
Counter current immunoelctreophoresis was performed on 
the bacterial sonicates with Vi antiserum to test the presence 
of Vi polysaccharide. The sonicates of mutant strains 
failed to produce any line of precipitation indicated that Vi 
polysaccharide was not being accumulated intracellularly 
in ompR mutants, whereas wild strains were produced the 
precipitation band (Figure 3).
Sonicated Wild S. typhi isolate Vi antiserum
Precipitate band
Figure 3. Immunodiffusion pattern for sonicated S. typhi strain reacted 
with Vi antiserum.
3.4. Expression and regulation of the porins ompC and ompF 
in the SS3 and SS5 strains
  Because ompR is known to regulate expression of porin 
channel, in the present study we probe into the effect of 
the ompR mutation on the expression of ompC and ompF 
by comparing with outer membrane proteins of the mutant 
and wild type strains of S. typhi. The expression of ompC, 
ompF, and ompA in the mutants as well as in the wild type 
strains were analyzed by SDS-PAGE. We observed ompF, 
ompC and ompA were found to be 36 kDa, 35 kDa and 33 
kDa respectively in the wild type strain, whereas the mutant 
isolates showing only ompA which do not have porin forming 
properties. Thus, it was found that expression of ompC and 
ompF was down regulated in mutants (Figure 4).
250
97.4
66
43
29
1              2                3              4            5             6            7
-36 kDa
-35 kDa
-33 kDa
Figure 4. SDS-PAGE (10%) analysis of OMPs from S. typhi upon 
treatment with various concentrations of NaCl.
Lane 1-Protein molecular weight marker (GeNei, India), Lane 2-0.1 M 
NaCl osmolar induced S. typhi, Lane 3- 0.2 M NaCl osmolar induced 
S. typhi, Lane 4- 0.3 M NaCl osmolar induced S. typhi, Lane 5- 0.4 M 
NaCl osmolar induced S. typhi, Lane 6-0.5 M NaCl osmolar induced S. 
typhi, Lane 7- 0.6 M NaCl osmolar induced S. typhi.
3.5. Phenotypic characterization of SS3 and SS5 mutant 
strains
  Phenotypic test was carried out to identify the mutant 
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strains which were no longer agglutinated with Vi antiserum 
(Table 2). These strains were also screened for the presence 
of ompR deletions. From these results, it is suggested 
that the ompR component systems were involved in the 
regulation of Vi synthesis in S. typhi. 
Table 2 
Agglutination test of S. typhi mutants grown on LB agar with different 
osmolarity.
NaCl Con (M) in LB 
agar
Slide agglutination of  S. typhi with Vi antiserum
SS3 SS5
0.1 + +
0.2 + +
0.3 + +
0.4 + +
0.5 - -
0.6 - -
0.7 - -
3.6. Assessment of virulence in mice
  LD50 was found to be 3 log CFU.mL
-1 for SS3 and SS5 
strains in this study. The experimental animals died within 
72 h after inoculation intraperitoneally indicating these 
strains were virulent.  However, the mutant strain injected 
mice group showed no mortality or any clinical symptoms. 
Serum was collected from the mutant mice injected with the 
attenuated strains of SS3 and SS5. The collected serum was 
added with broth culture of SS3 and SS5 wild-type strains on 
a glass slide. Agglutination within 2 min was observed and 
the results indicated antibody was raised against the mutant 
isolates without any symptoms. The immunized animal’s 
serum antibody titre was found to be 1:60. This study 
obviously revealed that the mice immunized with attenuated 
strains were found to be protected with elicited humoral 
immune response.
4. Discussion 
  Typhoid fever continues to be an important infection in 
endemic countries and among travellers to these areas. 
Typhoid fever has been declining in many middle-income 
countries, whereas the bulk of cases occur in the Indian 
subcontinent and in south-east Asia[25].
  A total of 138 enteric fever cases were found in United 
Kingdom during 2005-2010. Of these 65% and 35% cases were 
caused by S. typhi and Salmonella paratyphi respectively. 
These individuals were acquired the infection form abroad 
in the age group 16-40 years and under 16 years. Indian, 
Pakisthani, Banhgladesh patients have been made the 
majority (87%) of the typhoid cases.  New entrant and foreign 
visitors accounted for 10% of the cases, 92% cases had a 
history of recent foreign travel; 57%patients had travelled 
to visit friends and relatives and 23% patients were new 
entrants / foreign visitors from the Indian subcontinent[26].
  Typhoid bacilli has become a major threat to the public 
due to the severity of the disease , recurrence of disease 
through asymptomatic carrier state[27] emergence of multi 
drug resistance[4,28] and its use as a potential candidate in 
bioterrorism[29], thereby it is necessary to develop potential 
candidate vaccine for typhoid fever[30]. 
  Attenuated strain development for bacterial vaccines by 
virulent gene knock out is one of the key research areas at 
present against infectious bacterial diseases prevention. 
In this study, we described a modified approach for the 
generation of mutant Salmonella strains to be attenuated 
against Salmonellosis in mice model study. Development 
of attenuated S. typhi strains and their ability to elicit 
protective immunity in animal models have already been 
reported[31,32]. It is proved that live attenuated vaccines elicit 
potent cell mediated responses. It has also been proved 
that the family of two component regulatory system genes 
responses to various environmental stimuli in bacteria and 
its involvement in bacterial virulence. Towards that end 
it has been studied that alterations in porin channel by 
demanding bacterial growth with the presence of sugars[33]. 
On such alteration in the ompC porin, R74C substitution 
(ompC R74C or ompC1 cys) has been reported. The ompC 
and ompF porin genes were transcriptionally regulated by 
a classical two component signal transduction regulatory 
system consistent of the ompR-envZ proteins[34,35]. 
Furthermore, Salmonella strains harbouring mutations in 
two component regulatory system of phoP-phoQ, could be 
attenuated to develop Salmonella vaccines[36]. 
  In vivo down regulation of Vi Ag provides proof of 
principle that it is possible to generate a live attenuated 
vaccine that induces specific antibodies after single oral 
administration[37].
  The WHO has been recommended for the programmatic 
use of new-generation typhoid vaccines in high-risk areas 
of countries where typhoid fever is still endemic. Past and 
current typhoid vaccination programs that have taken place 
in Thailand (using the old whole-cell vaccine) and in China, 
Vietnam and India (using the new-generation injectable 
Vi polysaccharide vaccine)[38]. Vi polysaccharide vaccine 
will not protect the patients if S. typhi strains are negative 
for Vi polysaccharide. The recent data of the community 
vaccination in high incidence areas of Kolkata, Karachi, and 
north Jakarta showed the cost effectives of Vi polysaccharide 
vaccine in children[39].
  It is well documented that ompR gene of S. typhi is 
involved in the regulation of the synthesis of Vi capsular 
Senthilkumar B et al./Asian Pacific Journal of Tropical Medicine (2014)933-939938
polysaccharide in response to osmolority. Considering all 
these facts we used high osmolar conditions to study the 
effect of ompR gene regulation in the Salmonella isolates 
from asymptomatic typhoid carriers. Remarkably, in 
agreement with, Pickard et al[1], we found that Vi expression 
is very sensitive with osmolarity of the growth medium. 
Interestingly, our results showed that 0.5, 0.6 and 0.7 M of 
NaCl yielded mutant attenuated strains which leads to 282 
bp PCR amplified products. We speculate that resulting 
mutant strains due to deletion of 517 bp in ompR gene. 
Moreover, as expected[22,40] in this study, the SDS-PAGE 
results showed that in the wild type isolates the outer 
membrane proteins viz. ompC, ompF and ompA were found 
to be 36, 35 and 33 kDa respectively. In contrast, the mutant 
strains only expressed omp A at 33 kDa, other two proteins of 
ompC and F were found to be down regulated. 
  In mice challenging study, the animals were died within 
72 h of intraperitoneal injection of wild type strains SS3 
and SS5 indicating that the strains were virulent, whereas, 
no clinical symptoms were observed when the mice were 
intraperitoneally injected with the high concentration NaCl 
osmolar stress induced ompR mutant strains alternatively, 
they produce antibody titre after 15 days. 
  In 2007, a live attenuated vaccine against typhoid fever 
DV-STM-07 has been shown to be potent in murine 
model of salmonellosis[41]. The vaccine developed through 
independent chemical conjugation of Vi polysaccharide of 
S. typhi and o polysaccharide of S. paratyphi A to CRM197, a 
non toxic mutant of diphtheria toxin. The vaccine was found 
to be inducing humoral response than unconjugated Vi 
polysaccharide[42].
  With these findings, we believe that the NaCl osmolar stress 
induced mutants may be used for vaccine development. 
In conclusion, this is the first time, we report that S. typhi 
isolated from asymptomatic typhoid carriers with its down 
regulated expression of Vi polysaccharide upon NaCl 
osmolar stress induced deletion mutation in ompR gene 
would be a rational object against which to elicit antibody 
for a candidate of typhoid vaccine.
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